Gaël Roué

10.6k total citations
101 papers, 3.0k citations indexed

About

Gaël Roué is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Gaël Roué has authored 101 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 36 papers in Genetics and 32 papers in Pathology and Forensic Medicine. Recurrent topics in Gaël Roué's work include Chronic Lymphocytic Leukemia Research (36 papers), Lymphoma Diagnosis and Treatment (31 papers) and Ubiquitin and proteasome pathways (25 papers). Gaël Roué is often cited by papers focused on Chronic Lymphocytic Leukemia Research (36 papers), Lymphoma Diagnosis and Treatment (31 papers) and Ubiquitin and proteasome pathways (25 papers). Gaël Roué collaborates with scholars based in Spain, France and United States. Gaël Roué's co-authors include Dolors Colomer, Elı́as Campo, Patricia Pérez‐Galán, Neus Villamor, Emili Montserrat, Mònica López‐Guerra, Laia Rosich, Sílvia Xargay‐Torrent, Santos A. Susín and Antonio Martı́nez and has published in prestigious journals such as Blood, The Journal of Immunology and Molecular and Cellular Biology.

In The Last Decade

Gaël Roué

100 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gaël Roué Spain	33	1.7k	864	699	568	552	101	3.0k
Manfred Jücker Germany	30	2.0k 1.1×	904 1.0×	451 0.6×	270 0.5×	518 0.9×	104	3.2k
Stephen K. Tahir United States	22	2.4k 1.4×	980 1.1×	308 0.4×	344 0.6×	391 0.7×	35	3.3k
Meike Vogler Germany	26	2.1k 1.2×	769 0.9×	256 0.4×	396 0.7×	563 1.0×	59	2.9k
Cassandra J. Vandenberg Australia	19	2.2k 1.2×	912 1.1×	265 0.4×	268 0.5×	553 1.0×	44	2.9k
Wayne Pearce United Kingdom	24	2.1k 1.2×	808 0.9×	294 0.4×	815 1.4×	1.6k 2.8×	30	3.7k
Joseph Gera United States	28	2.4k 1.4×	592 0.7×	335 0.5×	208 0.4×	376 0.7×	60	3.0k
Ryan M. Young United States	19	976 0.6×	809 0.9×	1.2k 1.8×	753 1.3×	741 1.3×	36	2.6k
Athos Gianella-Borradori Switzerland	22	968 0.6×	883 1.0×	513 0.7×	267 0.5×	280 0.5×	52	2.5k
Stefan Hart Singapore	23	1.4k 0.8×	1.0k 1.2×	215 0.3×	413 0.7×	221 0.4×	30	2.7k
Alexandre Arcaro Switzerland	31	2.6k 1.5×	659 0.8×	271 0.4×	351 0.6×	761 1.4×	51	3.9k

Countries citing papers authored by Gaël Roué

Since Specialization

Citations

This map shows the geographic impact of Gaël Roué's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaël Roué with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaël Roué more than expected).

Fields of papers citing papers by Gaël Roué

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaël Roué. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaël Roué. The network helps show where Gaël Roué may publish in the future.

Co-authorship network of co-authors of Gaël Roué

This figure shows the co-authorship network connecting the top 25 collaborators of Gaël Roué. A scholar is included among the top collaborators of Gaël Roué based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaël Roué. Gaël Roué is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xolalpa, Wendy, Raimundo Freire, Julie Guillermet‐Guibert, et al.. (2025). Role of TRIM24 in the regulation of proteasome-autophagy crosstalk in bortezomib-resistant mantle cell lymphoma. Cell Death Discovery. 11(1). 108–108. 1 indexed citations

Chamorro-Jorganes, Aránzazu, Juan García Valero, Diana Reyes-Garau, et al.. (2025). YPEL2 regulates the efficacy of BRD4-EZH2 dual targeting in EZH2Y641mut germinal center-derived lymphoma. Neoplasia. 61. 101131–101131. 2 indexed citations

Campillo‐Marcos, Ignacio, Verónica Dávalos, Gerardo Ferrer, et al.. (2024). Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy. Cancer Research Communications. 4(2). 365–377. 6 indexed citations

Bellanger, Céline, Yannick Le Bris, Juliana C. Santos, et al.. (2023). CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma. Blood. 142(18). 1543–1555. 11 indexed citations

Ribeiro, Marcelo Lima, et al.. (2023). Narazaciclib, a Differentiated CDK4/6 Antagonist, Prolongs Cell Cycle Arrest and Metabolomic Reprogramming, Enabling Restoration of Ibrutinib Sensitivity in Btki-Resistant Mantle Cell Lymphoma. Blood. 142(Supplement 1). 4181–4181.

Bonnin, Sarah, Carlos Martínez, Talía Velasco-Hernández, et al.. (2021). Distinct roles for PARP-1 and PARP-2 in c-Myc–driven B-cell lymphoma in mice. Blood. 139(2). 228–239. 24 indexed citations

Balsas, Patricia, Vanina Rodríguez, Juan García Valero, et al.. (2017). Activity of the novel BCR kinase inhibitor IQS019 in preclinical models of B-cell non-Hodgkin lymphoma. Journal of Hematology & Oncology. 10(1). 80–80. 7 indexed citations

Matas‐Céspedes, Alba, Vanina Rodríguez, Neus Villamor, et al.. (2016). The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia–Microenvironment Interactions in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 23(6). 1493–1505. 45 indexed citations

Barrios, Oriol de, Balázs Győrffy, María Jesús Fernández‐Aceñero, et al.. (2016). ZEB1-induced tumourigenesis requires senescence inhibition via activation of DKK1/mutant p53/Mdm2/CtBP and repression of macroH2A1. Gut. 66(4). 666–682. 32 indexed citations

10.

Maliandi, María Victoria, et al.. (2015). AduPARE1A and gemcitabine combined treatment trigger synergistic antitumor effects in pancreatic cancer through NF-κB mediated uPAR activation. Molecular Cancer. 14(1). 146–146. 6 indexed citations

11.

Matas‐Céspedes, Alba, Vanina Rodríguez, Susana G. Kalko, et al.. (2014). Disruption of Follicular Dendritic Cells–Follicular Lymphoma Cross-talk by the Pan-PI3K Inhibitor BKM120 (Buparlisib). Clinical Cancer Research. 20(13). 3458–3471. 21 indexed citations

12.

Bellacasa, Raimon Puig de la, Gaël Roué, Patricia Balsas, et al.. (2014). 4-Amino-2-arylamino-6-(2,6-dichlorophenyl)-pyrido[2,3-d]pyrimidin-7-(8H)-ones as BCR kinase inhibitors for B lymphoid malignancies. European Journal of Medicinal Chemistry. 86. 664–675. 23 indexed citations

13.

Moros, Alexandra, Julie Cahu, Ifigènia Saborit-Villarroya, et al.. (2013). Antitumoral Activity of Lenalidomide in In Vitro and In Vivo Models of Mantle Cell Lymphoma Involves the Destabilization of Cyclin D1/p27KIP1 Complexes. Clinical Cancer Research. 20(2). 393–403. 17 indexed citations

14.

Xolalpa, Wendy, Patricia Pérez‐Galán, Manuel S. Rodríguez, & Gaël Roué. (2013). Targeting the Ubiquitin Proteasome System: Beyond Proteasome Inhibition. Current Pharmaceutical Design. 19(22). 4053–4093. 23 indexed citations

15.

Saborit-Villarroya, Ifigènia, Sílvia Xargay‐Torrent, Arnau Montraveta, et al.. (2013). The phosphatidylinositol-3-kinase inhibitor NVP-BKM120 overcomes resistance signals derived from microenvironment by regulating the Akt/FoxO3a/Bim axis in chronic lymphocytic leukemia cells. Haematologica. 98(11). 1739–1747. 34 indexed citations

16.

Rosich, Laia, Sílvia Xargay‐Torrent, Mònica López‐Guerra, et al.. (2012). Counteracting Autophagy Overcomes Resistance to Everolimus in Mantle Cell Lymphoma. Clinical Cancer Research. 18(19). 5278–5289. 57 indexed citations

17.

Mollinedo, Faustino, Janis de la Iglesia-Vicente, Consuelo Gajate, et al.. (2010). In vitro and In vivo Selective Antitumor Activity of Edelfosine against Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia Involving Lipid Rafts. Clinical Cancer Research. 16(7). 2046–2054. 81 indexed citations

18.

Saborit-Villarroya, Ifigènia, Gaël Roué, Mònica López‐Guerra, et al.. (2010). Cell Death Targeting Therapies in B Lymphoid Malignancies. Current Drug Targets. 11(7). 769–780. 1 indexed citations

19.

Barbier, Sandrine, Laurent Châtre, Morgane Le Bras, et al.. (2009). Caspase-independent type III programmed cell death in chronic lymphocytic leukemia: the key role of the F-actin cytoskeleton. Haematologica. 94(4). 507–517. 21 indexed citations

20.

Roué, Gaël, Patricia Pérez‐Galán, Mònica López‐Guerra, et al.. (2007). Selective Inhibition of IκB Kinase Sensitizes Mantle Cell Lymphoma B Cells to TRAIL by Decreasing Cellular FLIP Level. The Journal of Immunology. 178(3). 1923–1930. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact